Founder and CEO, Bakx Therapeutics
Sree Kant is an experienced biotech executive, and company builder. Over a 20-year career in life sciences and healthcare, Sree has worked across investing, operational, advisory, and entrepreneurial roles and functions. He is passionate about translating cutting edge science into therapies that significantly change health outcomes for patients.
Before founding BAKX, Sree headed the Investments and Partnerships function at Life Biosciences, where he built platform focused companies in the areas of age-related diseases. He also took on operational roles in the portfolio companies driving the corporate development agenda. Prior to Life bio, Sree led early partnering strategy for Pfizer, driving strategic partnerships across different therapeutic areas/technologies and geographies. He also built Pfizer’s early target partnering vehicle and drove academic partnerships and spinouts to advance novel target platforms. Sree was also Principal at the Boston Consulting Group advising large pharma, biotech, and medical device companies in areas of Corporate development, R&D strategy, M&A, etc. Sree started his career with Ranbaxy labs in New Delhi and London, and also was a founding member of India’s first preventative, managed health company. Sree has an MBA from the Indian Institute of Management, and an MPH from the Harvard School of Public Health.